Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aspirin/dipyridamole extended release

Drug Profile

Aspirin/dipyridamole extended release

Alternative Names: Aggrenox; Asasantin; Asasantin 200/25 Retard; Asasantin Retard; Asasantin SR; Dipyridamole-extended release/aspirin

Latest Information Update: 02 Jul 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Class Antiplatelets; Salicylates; Small molecules; Vasodilators
  • Mechanism of Action Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Stroke; Transient ischaemic attacks

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 01 Jul 2015 Generic equivalent available in USA for Stroke (Prevention)
  • 14 May 2008 Efficacy and safety data from the PRoFESS trial released by Boehringer Ingelheim ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top